Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-13-084832
Filing Date
2013-11-14
Accepted
2013-11-14 16:17:25
Documents
10
Period of Report
2013-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q a13-19804_110q.htm 10-Q 898731
2 EX-31.1 a13-19804_1ex31d1.htm EX-31.1 9296
3 EX-31.2 a13-19804_1ex31d2.htm EX-31.2 9261
4 EX-32.1 a13-19804_1ex32d1.htm EX-32.1 7857
  Complete submission text file 0001104659-13-084832.txt   6248621

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT kyth-20130930.xml EX-101.INS 534513
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT kyth-20130930.xsd EX-101.SCH 70356
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT kyth-20130930_cal.xml EX-101.CAL 50938
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT kyth-20130930_def.xml EX-101.DEF 408219
9 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT kyth-20130930_lab.xml EX-101.LAB 1188806
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT kyth-20130930_pre.xml EX-101.PRE 581633
Mailing Address 27200 WEST AGOURA ROAD SUITE 200 CALABASAS CA 91301
Business Address 27200 WEST AGOURA ROAD SUITE 200 CALABASAS CA 91301 818-587-4500
KYTHERA BIOPHARMACEUTICALS INC (Filer) CIK: 0001436304 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35663 | Film No.: 131220253
SIC: 2834 Pharmaceutical Preparations